MORE: Newly approved weight-loss pills could expand access to GLP-1s The study, published Wednesday in the journal Nature, surveyed more than 27,000 people in the 23andMe genetic database about their responses to the GLP-1 drugs semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)
Cancer 35 , 13201325 (1999)
If cost or access is a barrier to continuing medication, talk to your provider about lower-cost alternatives, dose reduction strategies, or manufacturer savings programs
While studies have found other health benefits beyond weight loss and better blood sugar levels, the medications effects on mental health have been unclear
Membranes were washed with PBST, blocked with 5% non-fat milk, and incubated with the antibodies indicated (Supplementary Table 2)
Compounded semaglutide also provides two main benefits over its name-brand counterparts: Cost and availability